Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.

Petratos, Steven

Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. [electronic resource] - Brain : a journal of neurology Jun 2012 - 1794-818 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1460-2156

10.1093/brain/aws100 doi


Adult
Analysis of Variance
Animals
Antibodies--therapeutic use
Axons--metabolism
CD3 Complex--metabolism
Cell Line, Tumor
Demyelinating Diseases--etiology
Disease Models, Animal
Encephalomyelitis, Autoimmune, Experimental--complications
Female
GPI-Linked Proteins--antagonists & inhibitors
Gene Expression Regulation--genetics
Glycoproteins--adverse effects
Green Fluorescent Proteins--genetics
Humans
Immunoprecipitation
Intercellular Signaling Peptides and Proteins--genetics
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Middle Aged
Multiple Sclerosis--complications
Mutation--genetics
Myelin Proteins--antagonists & inhibitors
Myelin-Oligodendrocyte Glycoprotein
Nerve Degeneration--etiology
Nerve Tissue Proteins--genetics
Neuroblastoma--pathology
Neurofilament Proteins--metabolism
Nogo Receptor 1
Optic Nerve--metabolism
Peptide Fragments--adverse effects
Phosphorylation
Receptors, Cell Surface--antagonists & inhibitors
Retinal Ganglion Cells--metabolism
Severity of Illness Index
Silver Staining
Spinal Cord--metabolism
Time Factors
Transduction, Genetic
Tubulin--metabolism
tau Proteins--metabolism